Xiamen Neore Pharmaceutical Technology Co., Ltd. is a leading manufacturer, supplier, and factory of 2-(cyclohexylamino)-1-(4-(hydroxymethyl)phenyl)ethanol, which is also known as 27025-41-8. This product is mainly used in the production of pharmaceuticals, including cardiovascular drugs and medicines for the treatment of hypertension.
27025-41-8 has also been found to have potential as a cancer treatment through its ability to inhibit the growth and proliferation of cancer cells. As a result, it has become a popular research subject for cancer researchers worldwide.
Xiamen Neore Pharmaceutical Technology Co., Ltd. is dedicated to producing high-quality products that meet the unique needs of each customer. The company adheres to strict quality standards in its manufacturing processes to ensure that the products it produces are safe, reliable, and effective.
As one of the leading companies in China, Xiamen Neore Pharmaceutical Technology Co., Ltd. is committed to providing customers with the best possible products and services. The company has earned a reputation for excellence in the industry and is poised to remain at the forefront of innovation for years to come.